−3.9832USD
−7.79 MUSD
6.26 M
About Dermata Therapeutics, Inc.
Sector
CEO
Gerald T. Proehl
Headquarters
San Diego
Website
Employees (FY)
8
Founded
2014
FIGI
BBG01248ZHS6
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
